Papillon Pharmaceutical Solutions SPRL
Papillon Pharmaceutical Solutions reported total assets of €1.67m at the end of the 2024 financial year (annual accounts filed with the NBB on 30 Sep 2025).
The score of Papillon Pharmaceutical Solutions shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2021 → 2024: Equity +100 % Total assets +58 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Papillon Pharmaceutical Solutions's annual accounts
Filed annual accounts
- Year ended 31 Dec 2024filed on 30 Sep 2025
- Year ended 31 Dec 2023filed on 29 Aug 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
- Year ended 31 Dec 2019filed on 31 Oct 2020
Papillon Pharmaceutical Solutions's financial analysis
- Solvency91.8%sector median: 58.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Papillon Pharmaceutical Solutions
1 active director(s) in the register.
Papillon Pharmaceutical Solutions's shareholders and holdings →Papillon Pharmaceutical Solutions's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0679.971.582
- VAT number
- BE0679971582
- Peppol
- Registered · 0208:0679971582 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 23 Aug 2017
- Registered office
- 9000 Ghent
- Latest accounts
- 2024 · filed on 30 Sep 2025
- Activity
- Business and other management consultancy activities (NACE 70200)
Papillon Pharmaceutical Solutions (SPRL) has been based in Ghent since 2017, active in: business and other management consultancy activities. For 2024, it reports a net profit of 203,271 € and equity of €1.53m; its revenue is not published. Its solvency stands at 91.8%, above the median of its sector (58.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Papillon Pharmaceutical Solutions
Companies in the same business, of comparable size and area, outside its group.
- Servas Business and other management consultancy activities Diepenbeek · balance sheet €1.67m
- Lionel van Reet Business and other management consultancy activities Overijse · balance sheet €1.66m
- Tactical Advisory Group Management Services Business and other management consultancy activities Leuven · balance sheet €1.67m
- VB&L Business and other management consultancy activities Ravels · balance sheet €1.67m
- Macbrien Cuper Isnard Business and other management consultancy activities Etterbeek · balance sheet €1.66m
- Pharos Business and other management consultancy activities Zwevegem · balance sheet €1.66m
- BENU Business and other management consultancy activities Opwijk · balance sheet €1.67m
- Baycross Management Services Business and other management consultancy activities Brussels · balance sheet €1.66m
Frequently asked questions about Papillon Pharmaceutical Solutions
What is the revenue of Papillon Pharmaceutical Solutions?
Papillon Pharmaceutical Solutions files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of Papillon Pharmaceutical Solutions?
In Belgium, the VAT number is the company number prefixed with BE: BE0679971582 for Papillon Pharmaceutical Solutions, if the company is VAT-registered. Its company number (CBE) is 0679.971.582.
Where is the registered office of Papillon Pharmaceutical Solutions?
According to the CBE register, the registered office of Papillon Pharmaceutical Solutions is in 9000 Ghent.
What is the equity of Papillon Pharmaceutical Solutions?
At the close of the 2024 financial year, the equity of Papillon Pharmaceutical Solutions amounts to 1,529,256 €, a solvency of 91.8% of total assets.
Who manages Papillon Pharmaceutical Solutions?
The register lists 1 active mandates at Papillon Pharmaceutical Solutions. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Papillon Pharmaceutical Solutions
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →